UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026174
Receipt number R000030076
Scientific Title Extracorporeal shockwave therapy in musculoskeletal disorders
Date of disclosure of the study information 2017/02/17
Last modified on 2019/10/03 15:02:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Extracorporeal shockwave therapy in musculoskeletal disorders

Acronym

Extracorporeal shockwave therapy in musculoskeletal disorders

Scientific Title

Extracorporeal shockwave therapy in musculoskeletal disorders

Scientific Title:Acronym

Extracorporeal shockwave therapy in musculoskeletal disorders

Region

Japan


Condition

Condition

enthesopathy
stress fracture
non union

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy of extracorporeal shock wave therapy in musculoskeletal disorders

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change of the pain after the extracorporeal shockwave therapy in enthesopathy, stress fracture and non union.

Key secondary outcomes

The period before making bone union after the extracorporeal shockwave therapy in enthesopathy, stress fracture and non union.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The extracorporeal shockwave was delivered to the tender area in enthesopathy or the fracture area.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

We follow the adaptation disease that the International Society for Medical Shockwave Treatment make a recommendation.

Key exclusion criteria

anticoagulant medication,
thrombotic disease,
malignant disorder,
pregnant woman,
The patients who continue receiving cortisone treatment more than six months or the patient who does not pass from the last cortisone injection for six weeks.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Shinichi
Middle name
Last name Konno

Organization

Fukushima Medical University School

Division name

Department of Orthopedic Surgery

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima City, Fukushima, Japan

TEL

024-547-1276

Email

fortho@fmu.ac.jp


Public contact

Name of contact person

1st name Takahiro
Middle name
Last name Igari

Organization

Fukushima Medical University School

Division name

Department of Orthopedic Surgery

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima City, Fukushima, Japan

TEL

024-547-1276

Homepage URL


Email

igataka@fmu.ac.jp


Sponsor or person

Institute

Department of Orthopedic Surgery, Fukushima Medical University School

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medical University School

Address

1 Hikarigaoka, Fukushima City, Fukushima, Japan

Tel

0245471276

Email

igataka@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 01 Day

Date of IRB

2016 Year 12 Month 27 Day

Anticipated trial start date

2017 Year 02 Month 20 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 16 Day

Last modified on

2019 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030076


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name